Regeneron Pharmaceuticals Inc at J.P. Morgan 2020 Biotech Conference Call Series Transcript
Welcome, and thank you for standing by. I would like to inform all participants that this conference is being recorded and will be available to clients of JP Morgan. Parts of this conference may also be reproduced in JPMorgan Research. If you have any objections, you may disconnect at this time. This call is not intended for EEA clients that only subscribe for written research, and members of the press are not permitted on this call. If you are with the press or subject of the MiFID II and do not have high-touch access, please disconnect now. (Operator Instructions)
And would now like to turn over the call to your host, Mr. Cory Kasimov, you may begin.
Great. Thank you, operator. Good afternoon, everyone. My name is Cory Kasimov. I'm a Senior Biotechnology Analyst at JPMorgan, and I'm here with Matthew Holt from our team. Thanks for joining us for the latest installment of our 2020 Biotech Conference Call series.
Today, it's our pleasure to be
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
